国际麻醉学与复苏杂志   2011, Issue (4): 13-13
    
1-磷酸鞘氨醇与肺缺血再灌注损伤
祝卿, 林丽娜, 方向明1()
1.杭州市城站路58号浙一医院麻醉科
The effect of Sphingosine 1-phosphate in pulmonary ischemia reperfusion injury
 全文:
摘要:

1-磷酸鞘氨醇( Sphingosine-1-phosphate,S1P)是鞘脂的代谢产物,不仅与细胞表面特定受体(S1PR1-5)结合产生多种生物学效应,还作为细胞内第二信使发挥作用。S1P通过调节和参与细胞增殖、迁移、凋亡等机制,参与到生物体内心血管、免疫等系统的诸多重要生理和病理过程。新近研究表明,S1P通过调控炎症反应、减少细胞凋亡以及维持血管内皮屏障完整,与肺缺血再灌注损伤(pulmonary ischemia reperfusion injury,PIRI) 的发生发展存在密切关系。本文基于近年来的研究进展,对S1P在PIRI中的作用进行综述。

关键词: 1-磷酸鞘氨醇;肺;缺血再灌注
Abstract:

Sphingosine 1-phosphate (S1P) is a sphingolipid metabolite. Many of its functions are regulated by binding the specific receptor (S1P G-protein-coupled receptors, S1PR1–5) on cell surface; however, S1P can also act as an intracellular second messenger. S1P has a pivotal role in cell proliferation, migration, apoptosis, and involves in some physiological and pathological progress of cardiovascular system, immune system and et al. Thus, it Recent studies suggest that, through regulating inflammation, anti-apoptosis and maintaining endothelial cell barrier, S1P can affect the occurrence and development of pulmonary ischemia reperfusion injury (PIRI).This article intends to provide a review about the function of S1P in PIRI, based on published data recently.

Key words: Sphingosine-1-phosphate;lung;ischemia reperfusion